Type 1 diabetes: open trials in Denmark

35 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

NCT05585983
INfluenza VaccInation To Mitigate typE 1 Diabetes
Trial Treatment · Phase 4 · Aarhus University Hospital
Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus · Steno Diabetes Center Copenhagen, Copenhagen · Gødstrup Hospital, Herning · Holbaek Sygehus, Holbæk · Nykoebing F Sygehus, Nykøbing Falster · Randers Regional Hospital, Randers · Sjællands Universitetssygehus, Roskilde · Slagelse Hospital, Slagelse · Viborg Regional Hospital, Viborg
Registry updated 2026-10-28
NCT06072326
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
Trial Treatment · Phase 2 · University Medical Center Groningen
Steno Diabetes Center Aarhus, Arhus · Steno Diabetes Center Copenhagen, Herlev · Regionshospitalet Gødstrup, Herning
Registry updated 2026-10-20
NCT07187531
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Trial Treatment · Phase 2 · SAb Biotherapeutics, Inc.
Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-10-13
2023-505794-32-04
New treatments to reduce cardiovascular disease in type 1 diabetes
Trial Treatment · Phase 3 · Steno Diabetes Center Copenhagen
Steno Diabetes Center Nordjylland, Aalborg · Steno Diabetes Center Aarhus, Arhus · Bispebjerg Hospital, Copenhagen Nv · Rigshospitalet, Copenhagen Oe · Sydvestjysk Sygehus, Esbjerg · Steno Diabetes Center Copenhagen, Herlev · Region Midtjylland, Herning · Nordsjællands Hospital, Hillerød · Holbæk Sygehus, Holbæk · Region Midtjylland, Horsens · Hvidovre Hospital, Hvidovre · Sjællands Universitetshospital, Køge · Lillebaelt Hospital, Kolding · Nykøbing Falster Sygehuse, Nykøbing Falster · Steno Diabetes Center Odense, Odense · Region Midtjylland, Randers Noe · Region Midtjylland, Silkeborg · Slagelse Sygheus, Slagelse · Region Midtjylland, Viborg
Registry updated 2026-10-05
NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Region Midtjylland, Aarhus N · Sanos A/S, Gandrup · Steno Diabetes Center Copenhagen, Herlev · Sanos A/S, Herlev · Holbaek Sygehus, Holbæk · Hvidovre Hospital, Hvidovre · Faenosundlaegerne I/S, Middelfart · Region Syddanmark, Odense C · Sanos A/S, Vejle
Registry updated 2026-09-25
NCT05663515
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Research · AstraZeneca
Copenhagen
Registry updated 2026-09-24
NCT07227805
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
Trial Treatment · Medtronic MiniMed, Inc.
steno diabetes center Aarhus, Aarhus · Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-09-21
2025-523414-89-00
Effects of semaglutide as add-on therapy to sulfonylurea on plasma glucose in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SEMA)
Trial Treatment · Phase 2 · Steno Diabetes Center Copenhagen
Aarhus University Hospital, Aarhus · Steno Diabetes Center Copenhagen, Herlev · Odense University Hospital, Odense
Registry updated 2026-09-08
2022-500906-17-01
INVITED trial
Trial Treatment · Phase 2 · Aarhus University Hospital
Aalborg University Hospital, Aalborg · Aarhus University, Aarhus N · Steno Diabetes Center Copenhagen, Herlev · Region Midtjylland, Herning · Holbaek Sygehus, Holbæk · Nykoebing F Sygehus, Nykobing F · Regionshospitalet Randers, Randers Nø · Region Sjaelland, Roskilde · Slagelse Hospital, Slagelse · Region Midtjylland, Viborg
Registry updated 2026-09-07
NCT07767461
Exploring Skin Barrier Function, Recurrence of Diabetes Device-Related Contact Dermatitis, and Evaluation of Hydrocolloid and Silicone-Based Patches for Its Prevention in Children and Adolescents With Type 1 Diabetes
Trial Treatment · Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen, Copenhagen
Registry updated 2026-08-25
NCT07774780
Oral Galactose as a Substrate for Post-Exercise Skeletal Muscle Glycogen Repletion in Individuals With Type 1 Diabetes
Trial Treatment · University of Aarhus
steno diabetes center Aarhus, Aarhus · Aarhus Universitet, Aarhus
Registry updated 2026-08-19
NCT07427251
The Postprandial Hypo-Avoid Study
Trial Treatment · Phase 4 · Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-08-13
NCT07240012
Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes
Trial Treatment · Copenhagen University Hospital, Rigshospitalet
Department of Gynecology and Obstetrics, Aalborg University Hospital, Aalborg · Steno Diabetes Center Nordjylland, Aalborg · Department of Gynecology and Obstetrics, Aarhus University Hospital, Aarhus · steno diabetes center Aarhus, Aarhus · Steno Diabetes Center Copenhagen, Copenhagen · Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen · Department of Gynecology and Obstetrics, Odense University Hospital, Odense · Steno Diabetes Center Odense, Odense University Hospital, Odense
Registry updated 2026-08-12
NCT07617519
Changing Outpatient Diabetes Care With Remote-Patient-Monitoring: A Real World Evidence Study With Pre-Post Comparison
Research · Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-07-17
NCT07416656
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Research · Klavs Würgler Hansen
Medical Diagnostic Center, Silkeborg
Registry updated 2026-06-25
NCT07596160
Individualized Exercise Consultation in Type 1 Diabetes
Trial Treatment · University of Aarhus
steno diabetes center Aarhus, Aarhus
Registry updated 2026-06-09
NCT06936280
Type 1 Diabetes and Diabetes Distress
Trial Treatment · Odense University Hospital
Esbjerg Hospital, Esbjerg · Odense University Hospital, Odense · Sønderborg Hospital, Sønderborg
Registry updated 2026-04-09
2025-523996-45-00
The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes
Trial Treatment · Phase 4 · Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-03-16
NCT07474155
Steno780G Follow-up Study
Research · Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-03-16
2025-524679-22-00
Up-titration of sulfonylurea (SU) in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SUUP)
Trial Treatment · Phase 2 · Steno Diabetes Center Copenhagen
Aarhus University Hospital, Aarhus N · Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-03-04
NCT07374705
Disentangling the Effect of Brain Insulin Resistance on Brain Health
Research · Henrik Bo Wiberg Larsson
Rigshospitalet, Glostrup Municipality · Steno Diabetes Center Copenhagen, Herlev
Registry updated 2026-02-25
NCT07270172
The MICRON Study - A Steno 1 Substudy
Research · University of Aarhus
Aarhus University Hospital, Aarhus N · Regionshospitalet Gødstrup, Gødstrup · Regionshospitalet Horsens, Horsens · Regionshospitalet Silkeborg, Silkeborg · Regionshospitalet Vibrg, Viborg
Registry updated 2026-02-02
NCT07373392
Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus
Trial Treatment · Aalborg University
Department of Health Science and Technology, Aalborg University, Gistrup · Steno Diabetes Center Nordjylland, Gistrup
Registry updated 2026-01-29
NCT07247734
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
Trial Treatment · Phase 2 · Asger Lund, MD
Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Capital Region 2900, Gentofte Municipality
Registry updated 2025-12-23
2025-522528-29-00
The effect of colchicine, on insulin sensitivity in individuals with type 1 diabetes and systemic low-grade inflammation (INS1GHT)
Trial Treatment · Phase 2 · Gentofte Hospital
Gentofte Hospital, Hellerup
Registry updated 2025-09-26

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error